Prostate Cancer Clinical Trials in Portland

Showing 121-122 of 122 trials

Study of Aranesp to Treat Anemia in Prostate Cancer Patients.

NCT00245895

The purpose of this study is to see if darbepoetin alfa is an effective treatment for anemia in prostate cancer patients and, if so, what dose is most effective. Sometimes prostate cancer patients have low red blood cell counts (low hemoglobin) from various treatments they are receiving, such as chemotherapy. The red blood cells deliver oxygen to the tissue. This then helps give the patient more energy.

Prostate CancerAnemia

University of Washington20 participantsStarted Apr 2003

Portland, Oregon, United States • Seattle, Washington, United States

COMPLETEDPHASE2< 1 mile

Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy

NCT00100243

This is a Phase 2, open-label study in subjects with androgen-independent prostate cancer who have progressed following treatment with an LHRH agonist. Up to 22 subjects will be enrolled. Enrollment will be monitored to ensure that not all subjects are enrolled based on rising prostate specific antigen (PSA) criterion only. Subjects will be treated with abarelix (Plenaxis) 100 mg intramuscularly (IM) every 2 weeks for 12 weeks (total dose of 600 mg).

Prostate Cancer

PRAECIS Pharmaceuticals Inc.22 participantsStarted May 2004

La Mesa, California, United States • Fort Myers, Florida, United States • Panama City, Florida, United States +4 more locations

Study of Aranesp to Treat Anemia in Prostate Cancer Patients.

Study of Abarelix in Androgen-Independent Prostate Cancer Progressing After Agonist Therapy

Prostate Cancer Trials in Other Cities

Other Conditions in Portland